What amount sold does US Pharmatech Inc. report in Form D filings?

The latest linked filings report $3.4M sold across 1 identified offering(s). 0 unlinked amendment(s) are excluded; 0 offering(s) have no reported amount sold. This is not verified lifetime funding or money raised during a specific period.

When was US Pharmatech Inc.'s most recent SEC filing?

US Pharmatech Inc.'s most recent Form D filing was on 2026-01-16.

How many investors does US Pharmatech Inc. have?

The most recent Form D filing lists 1 investor(s).

What type of securities does US Pharmatech Inc. offer?

US Pharmatech Inc.'s SEC Form D filings indicate debt offerings.

US Pharmatech Inc.

CIK: 0002105777·Manufacturing·CERRITOS, CA·Corporation

Reported Sold

$3,403,700

Total Filings

Identified Offerings

Last Filed

Jan 16, 2026

Employees

—

Reported sold uses the latest linked filing for each identified offering; it is not verified lifetime funding. SPV filings are shown separately.

Offering filing timeline

Jan 16, 2026Form D — New notice

Reported sold: $3,403,700 · Target: $3,403,700

Rule 506(b)·1 investor

Fundraising Profile

Exemptions

Rule 506(b)

Investors in latest filing

Revenue Range

—

Reported commissions across identified offerings

Amendment Rate

Latest reported sold across 1 identified offering

$3,403,700

Uses the latest linked filing for each offering. This is not a measure of money raised in the last year or verified lifetime funding.

Key People

Dong Jun Lee

Executive Officer

Appears on 1 filing

Filing History

Date	Type	Offering target	Reported sold	Investors
Jan 16, 2026	New	$3,403,700	$3,403,700	1

Filing History

Amendment insights

Loading amendment history…

Comparable issuers

Matched on reported industry and issuer type, then ranked by business location, offering target, and recency. These are filing comparables, not verified business competitors.

SF Beverages, Inc.

Manufacturing

Offering target: $2,000,000

Filed Nov 5, 2026